Microbial Cell Bioprocessing
Providing microbial solutions for tomorrow’s technologies
The Microbial Cell Bioprocessing group utilises microbial systems for recombinant production of protein-based biologics, nucleic acids and other biotherapeutics. We develop technologies, bioprocessing and engineering strategies with sustainable biomanufacturing and clinical applications in mind. Our expertise in using Escherichia coli and lactic acid bacteria (LAB) cell factories as a production platform for cultivated meat, nucleic acid and other therapeutic applications can open opportunities for collaboration.
- Microbial biomanufacturing of protein biologics, recombinant growth factors and other therapeutic modalities
- Toolbox development for recombinant protein expression and secretion
- Customized microbial bioprocessing solutions
- Applications of LAB as live biotherapeutic products, protein expression systems and probiotics
A*STAR celebrates International Women's Day
From groundbreaking discoveries to cutting-edge research, our researchers are empowering the next generation of female science, technology, engineering and mathematics (STEM) leaders.
Get inspired by our #WomeninSTEM